Duran GE - Search Results

1

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers.

Moisan F, Francisco EB, Brozovic A, Duran GE, Wang YC, Chaturvedi S, Seetharam S, Snyder LA, Doshi P, Sikic BI. Moisan F, et al. Among authors: duran ge. Mol Oncol. 2014 Oct;8(7):1231-9. doi: 10.1016/j.molonc.2014.03.016. Epub 2014 Apr 18. Mol Oncol. 2014. PMID: 24816187 Free PMC article.

2

Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.

Lau DH, Durán GE, Sikic BI. Lau DH, et al. Among authors: duran ge. J Natl Cancer Inst. 1992 Oct 21;84(20):1587-92. doi: 10.1093/jnci/84.20.1587. J Natl Cancer Inst. 1992. PMID: 1404452

3

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism.

Lewis AD, Durán GE, Lau DH, Sikic BI. Lewis AD, et al. Among authors: duran ge. Int J Radiat Oncol Biol Phys. 1992;22(4):821-4. doi: 10.1016/0360-3016(92)90532-m. Int J Radiat Oncol Biol Phys. 1992. PMID: 1544857

4

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes.

Lewis AD, Lau DH, Durán GE, Wolf CR, Sikic BI. Lewis AD, et al. Among authors: duran ge. Cancer Res. 1992 Aug 15;52(16):4379-84. Cancer Res. 1992. PMID: 1643634

5

Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.

Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI. Beketic-Oreskovic L, et al. Among authors: duran ge. J Natl Cancer Inst. 1995 Nov 1;87(21):1593-602. doi: 10.1093/jnci/87.21.1593. J Natl Cancer Inst. 1995. PMID: 7563202

6

Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.

Jaffrézou JP, Chen KG, Durán GE, Muller C, Bordier C, Laurent G, Sikic BI, Levade T. Jaffrézou JP, et al. Among authors: duran ge. Biochim Biophys Acta. 1995 Apr 6;1266(1):1-8. doi: 10.1016/0167-4889(94)00219-5. Biochim Biophys Acta. 1995. PMID: 7718613 Free article.

7

Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.

Chen KG, Jaffrézou JP, Fleming WH, Durán GE, Sikic BI. Chen KG, et al. Among authors: duran ge. Cancer Res. 1994 Sep 15;54(18):4980-7. Cancer Res. 1994. PMID: 7915196

8

Volume-activated chloride current is not related to P-glycoprotein overexpression.

Dong Y, Chen KG, Durán GE, Kouyama K, Chao AC, Sikic BI, Gollapudi SV, Gupta S, Gardner P. Dong Y, et al. Among authors: duran ge. Cancer Res. 1994 Oct 1;54(19):5029-32. Cancer Res. 1994. PMID: 7923110

9

Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.

Lau DH, Duran GE, Lewis AD, Sikic BI. Lau DH, et al. Among authors: duran ge. Br J Cancer. 1994 Jul;70(1):79-84. doi: 10.1038/bjc.1994.253. Br J Cancer. 1994. PMID: 8018545 Free PMC article.

10

Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis.

Jaffrézou JP, Chen KG, Durán GE, Kühl JS, Sikic BI. Jaffrézou JP, et al. Among authors: duran ge. J Natl Cancer Inst. 1994 Aug 3;86(15):1152-8. doi: 10.1093/jnci/86.15.1152. J Natl Cancer Inst. 1994. PMID: 8028036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters